AF Screening to prevent ischaemic Stroke (The ASPIRE study)
The ASPIRE study explores innovative approaches to atrial fibrillation (AF) screening with the goal of preventing ischaemic stroke. By integrating blood-based ECG analysis and genetic biomarkers, the study aims to improve early detection of AF and identify individuals at heightened risk. This validation research seeks to establish reliable, accessible tools that can transform clinical practice, reduce stroke incidence, and ultimately enhance patient outcomes through precision medicine.
